Metraipolis › archive › dc_c96303dbd98d
Atrial Fibrillation/Flutter in Transthyretin Cardiac Amyloidosis: Prevalence, Incidence, Clinical Predictors, and Effect of Tafamidis — Europe PMC PMID:41448121
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41448121
- DOI
- 10.1016/j.jacadv.2025.102470
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T10:29:34.691Z
- SHA-256 of the archived text
b1c296b55c7a564a90b7bf1de6905f49d7f2e536fa50837493202ee385c24b45- Stable URL of this page
https://metraipolis.com/documento/dc_c96303dbd98d
How to cite
Atrial Fibrillation/Flutter in Transthyretin Cardiac Amyloidosis: Prevalence, Incidence, Clinical Predictors, and Effect of Tafamidis — Europe PMC PMID:41448121 — Europe PMC (en), https://europepmc.org/article/MED/41448121 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c96303dbd98d (Metraipolis archive dc_c96303dbd98d, sha256 b1c296b55c7a564a90b7bf1de6905f49d7f2e536fa50837493202ee385c24b45)
BibTeX
@misc{dcc96303dbd98d,
title = {Atrial Fibrillation/Flutter in Transthyretin Cardiac Amyloidosis: Prevalence, Incidence, Clinical Predictors, and Effect of Tafamidis — Europe PMC PMID:41448121},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41448121},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c96303dbd98d; sha256 b1c296b55c7a564a90b7bf1de6905f49d7f2e536fa50837493202ee385c24b45},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41448121. Agents can read the archived copy with the MCP tool read_document.